Skip to main content
Danaher Corporation (DHR)
NYSE: DHR · Real-Time Price · USD
191.54
-3.28 (-1.68%)
May 9, 2025, 12:56 PM - Market open

Danaher Revenue by Segment
Period Ending Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Diagnostics
9.71B 9.79B 9.87B 9.76B 9.73B 9.58B 9.83B 10.25B
Diagnostics Growth
-0.20% 2.19% 0.41% -4.82% -8.06% -11.72% -8.72% -2.70%
Life Sciences
7.26B 7.33B 7.23B 7.15B 7.18B 7.14B 7.16B 9.23B
Life Sciences Growth
1.21% 2.63% 0.98% -22.50% -37.03% -47.38% -54.33% -40.57%
Biotechnology
6.85B 6.76B 6.65B 6.66B 6.83B 7.17B 7.64B 5.97B
Biotechnology Growth
0.22% -5.76% -12.93% 11.52% 67.16% 222.63% - -
Environmental and Applied Solutions
- - - - - - 4.95B 4.91B
Environmental and Applied Solutions Growth
- - - - - - 2.76% 3.20%

Operating Income by Segment
Period Ending Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Diagnostics
2.51B 2.63B 2.77B 2.69B 2.56B 2.41B 2.63B 2.85B
Diagnostics Growth
-1.80% 9.10% 5.25% -5.61% -20.70% -29.98% -21.29% 4.66%
Biotechnology
1.74B 1.63B 1.53B 1.56B 1.64B 1.91B 2.19B 1.77B
Biotechnology Growth
6.29% -14.88% -29.87% -11.81% 27.08% 175.47% - -
Life Sciences
845.00M 879.00M 738.00M 1.02B 1.12B 1.21B 1.37B 2.10B
Life Sciences Growth
-24.76% -27.30% -45.97% -51.57% -61.70% -67.58% -69.19% -51.92%
Environmental
- - - - - - 1.19B 1.19B
Environmental Growth
- - - - - - 12.34% 15.60%
Other
-334.00M -326.00M -323.00M -358.00M -392.00M -413.00M -417.00M -377.00M

Operating Metrics

Period Ending Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018
Recurring Revenue
19.52B 19.37B 16.90B 17.31B 17.96B 18.68B 19.17B 19.81B
Recurring Revenue Growth
8.70% 3.66% -11.81% -12.62% -11.81% -10.51% -18.76% -14.56%

Revenue by Geography
Period Ending Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
North America
10.25B 10.30B 10.11B 10.71B 11.20B 11.59B 12.68B 13.18B - -
North America Growth
-8.55% -11.20% -20.23% -18.75% -17.84% -17.00% -6.91% 1.22% - -
High Growth Markets
6.87B 6.87B 6.88B 7.23B 7.73B 8.28B 8.74B 8.95B - -
High Growth Markets Growth
-11.17% -17.03% -21.28% -19.12% -14.85% -9.26% -5.49% -3.47% - -
Western Europe
5.48B 5.46B 5.31B 5.58B 5.96B 6.35B 6.73B 6.81B - -
Western Europe Growth
-8.17% -14.04% -21.16% -18.06% -12.16% -8.13% -2.73% -3.45% - -
Other Developed Markets
1.23B 1.25B 1.27B 1.30B 1.33B 1.38B 1.41B 1.42B - -
Other Developed Markets Growth
-7.68% -9.21% -10.53% -8.99% -7.76% -5.92% -3.15% -3.66% - -

Operating Expense Breakdown
Period Ending Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019
Selling, General, and Administrative
7.81B 7.76B 7.77B 7.86B 8.18B 8.52B 8.68B 8.68B
Selling, General, and Administrative Growth
-4.53% -8.94% -10.43% -9.49% -4.55% 0.06% 0.65% 1.72%
Research and Development
1.60B 1.58B 1.55B 1.58B 1.61B 1.67B 1.72B 1.72B
Research and Development Growth
-0.93% -5.21% -9.78% -7.97% -7.10% -4.24% -3.92% -4.87%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.